aluates Reports

$ 0.0

Automative

Global GalNAc Delivery Technology Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-13U18588

BUY CHAPTERS

Global GalNAc Delivery Technology Market Research Report 2024

Code: QYRE-Auto-13U18588

Report

November 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Suzhou Ribo Life Science Co.,Ltd.

Sirnaomics

Ionis Pharmaceuticals

Alnylam

Arrowhead

Dicerna

Arbutus

Verve Therapeutics

Silence Therapeutics

HitGen LTD

Novo Nordisk (Dicerna)

Luye Life Sciences (GeneLeap Biotech)

GalNAc Delivery Technology Market

GalNAc is a ligand for the Asialoglycoprotein receptor (ASGPR), which is an endocytic receptor that is highly specifically expressed on the surface of hepatocytes and is almost undetectable in other cell types. ASGPR mediates the clathrin-dependent endocytosis, effectively transporting galactose-derived ligands from the cell surface to the cytoplasm. During this process, ASGPR appears on the cell surface within 15 minutes. Trivalent and tetravalent ligands exhibit higher affinity than monovalent and divalent ASGPR. Therefore, trivalent or tetravalent GalNAc moieties are covalently conjugated to siRNA with proprietary linker structures. In the GalNAc delivery system, GalNAc can bind to small interfering RNA (siRNA) or other therapeutic molecules to form complexes. These complexes enter the cells by binding to ASGPR on the surface of hepatocytes. Given the liver's crucial role in drug metabolism and clearance, this targeted delivery enhances therapeutic efficacy while reducing systemic side effects. The GalNAc delivery system shows great potential in drug development, particularly for treating liver-related diseases, genetic disorders, and certain cancers. By optimizing the chemical structure and conjugation methods of GalNAc, its targeting ability and biocompatibility can be further improved, thereby enhancing therapeutic outcomes.

The global GalNAc Delivery Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for GalNAc Delivery Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for GalNAc Delivery Technology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for GalNAc Delivery Technology in Cardiovascular Diseases is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of GalNAc Delivery Technology include Suzhou Ribo Life Science Co., Ltd, Sirnaomics, Novo Nordisk (Dicerna), Ionis Pharmaceuticals, Alnylam, Arrowhead, Dicerna, Arbutus, Verve Therapeutics, Silence Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for GalNAc Delivery Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GalNAc Delivery Technology.

The GalNAc Delivery Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GalNAc Delivery Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GalNAc Delivery Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GalNAc Delivery Technology Market Report

Report Metric	Details
Report Name	GalNAc Delivery Technology Market
Segment by Type	GalNAc-siRNA Based GalNAc-ASO Based
Segment by Application	Cardiovascular Diseases Metabolic Diseases Neurological Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Suzhou Ribo Life Science Co., Ltd, Sirnaomics, Novo Nordisk (Dicerna), Ionis Pharmaceuticals, Alnylam, Arrowhead, Dicerna, Arbutus, Verve Therapeutics, Silence Therapeutics, Luye Life Sciences (GeneLeap Biotech), Hitgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GalNAc Delivery Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the GalNAc Delivery Technology Market report?

Ans: The main players in the GalNAc Delivery Technology Market are Suzhou Ribo Life Science Co., Ltd, Sirnaomics, Novo Nordisk (Dicerna), Ionis Pharmaceuticals, Alnylam, Arrowhead, Dicerna, Arbutus, Verve Therapeutics, Silence Therapeutics, Luye Life Sciences (GeneLeap Biotech), Hitgen

What are the Application segmentation covered in the GalNAc Delivery Technology Market report?

Ans: The Applications covered in the GalNAc Delivery Technology Market report are Cardiovascular Diseases, Metabolic Diseases, Neurological Diseases, Other

What are the Type segmentation covered in the GalNAc Delivery Technology Market report?

Ans: The Types covered in the GalNAc Delivery Technology Market report are GalNAc-siRNA Based, GalNAc-ASO Based

Recommended Reports

Glucose Monitoring

Gene And Cell Therapy

Drug Delivery Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global GalNAc Delivery Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 GalNAc-siRNA Based

1.2.3 GalNAc-ASO Based

1.3 Market by Application

1.3.1 Global GalNAc Delivery Technology Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cardiovascular Diseases

1.3.3 Metabolic Diseases

1.3.4 Neurological Diseases

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global GalNAc Delivery Technology Market Perspective (2019-2030)

2.2 Global GalNAc Delivery Technology Growth Trends by Region

2.2.1 Global GalNAc Delivery Technology Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 GalNAc Delivery Technology Historic Market Size by Region (2019-2024)

2.2.3 GalNAc Delivery Technology Forecasted Market Size by Region (2025-2030)

2.3 GalNAc Delivery Technology Market Dynamics

2.3.1 GalNAc Delivery Technology Industry Trends

2.3.2 GalNAc Delivery Technology Market Drivers

2.3.3 GalNAc Delivery Technology Market Challenges

2.3.4 GalNAc Delivery Technology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top GalNAc Delivery Technology Players by Revenue

3.1.1 Global Top GalNAc Delivery Technology Players by Revenue (2019-2024)

3.1.2 Global GalNAc Delivery Technology Revenue Market Share by Players (2019-2024)

3.2 Global GalNAc Delivery Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by GalNAc Delivery Technology Revenue

3.4 Global GalNAc Delivery Technology Market Concentration Ratio

3.4.1 Global GalNAc Delivery Technology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by GalNAc Delivery Technology Revenue in 2023

3.5 Global Key Players of GalNAc Delivery Technology Head office and Area Served

3.6 Global Key Players of GalNAc Delivery Technology, Product and Application

3.7 Global Key Players of GalNAc Delivery Technology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 GalNAc Delivery Technology Breakdown Data by Type

4.1 Global GalNAc Delivery Technology Historic Market Size by Type (2019-2024)

4.2 Global GalNAc Delivery Technology Forecasted Market Size by Type (2025-2030)

5 GalNAc Delivery Technology Breakdown Data by Application

5.1 Global GalNAc Delivery Technology Historic Market Size by Application (2019-2024)

5.2 Global GalNAc Delivery Technology Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America GalNAc Delivery Technology Market Size (2019-2030)

6.2 North America GalNAc Delivery Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America GalNAc Delivery Technology Market Size by Country (2019-2024)

6.4 North America GalNAc Delivery Technology Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe GalNAc Delivery Technology Market Size (2019-2030)

7.2 Europe GalNAc Delivery Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe GalNAc Delivery Technology Market Size by Country (2019-2024)

7.4 Europe GalNAc Delivery Technology Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific GalNAc Delivery Technology Market Size (2019-2030)

8.2 Asia-Pacific GalNAc Delivery Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific GalNAc Delivery Technology Market Size by Region (2019-2024)

8.4 Asia-Pacific GalNAc Delivery Technology Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America GalNAc Delivery Technology Market Size (2019-2030)

9.2 Latin America GalNAc Delivery Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America GalNAc Delivery Technology Market Size by Country (2019-2024)

9.4 Latin America GalNAc Delivery Technology Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa GalNAc Delivery Technology Market Size (2019-2030)

10.2 Middle East & Africa GalNAc Delivery Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa GalNAc Delivery Technology Market Size by Country (2019-2024)

10.4 Middle East & Africa GalNAc Delivery Technology Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Suzhou Ribo Life Science Co., Ltd

11.1.1 Suzhou Ribo Life Science Co., Ltd Company Details

11.1.2 Suzhou Ribo Life Science Co., Ltd Business Overview

11.1.3 Suzhou Ribo Life Science Co., Ltd GalNAc Delivery Technology Introduction

11.1.4 Suzhou Ribo Life Science Co., Ltd Revenue in GalNAc Delivery Technology Business (2019-2024)

11.1.5 Suzhou Ribo Life Science Co., Ltd Recent Development

11.2 Sirnaomics

11.2.1 Sirnaomics Company Details

11.2.2 Sirnaomics Business Overview

11.2.3 Sirnaomics GalNAc Delivery Technology Introduction

11.2.4 Sirnaomics Revenue in GalNAc Delivery Technology Business (2019-2024)

11.2.5 Sirnaomics Recent Development

11.3 Novo Nordisk (Dicerna)

11.3.1 Novo Nordisk (Dicerna) Company Details

11.3.2 Novo Nordisk (Dicerna) Business Overview

11.3.3 Novo Nordisk (Dicerna) GalNAc Delivery Technology Introduction

11.3.4 Novo Nordisk (Dicerna) Revenue in GalNAc Delivery Technology Business (2019-2024)

11.3.5 Novo Nordisk (Dicerna) Recent Development

11.4 Ionis Pharmaceuticals

11.4.1 Ionis Pharmaceuticals Company Details

11.4.2 Ionis Pharmaceuticals Business Overview

11.4.3 Ionis Pharmaceuticals GalNAc Delivery Technology Introduction

11.4.4 Ionis Pharmaceuticals Revenue in GalNAc Delivery Technology Business (2019-2024)

11.4.5 Ionis Pharmaceuticals Recent Development

11.5 Alnylam

11.5.1 Alnylam Company Details

11.5.2 Alnylam Business Overview

11.5.3 Alnylam GalNAc Delivery Technology Introduction

11.5.4 Alnylam Revenue in GalNAc Delivery Technology Business (2019-2024)

11.5.5 Alnylam Recent Development

11.6 Arrowhead

11.6.1 Arrowhead Company Details

11.6.2 Arrowhead Business Overview

11.6.3 Arrowhead GalNAc Delivery Technology Introduction

11.6.4 Arrowhead Revenue in GalNAc Delivery Technology Business (2019-2024)

11.6.5 Arrowhead Recent Development

11.7 Dicerna

11.7.1 Dicerna Company Details

11.7.2 Dicerna Business Overview

11.7.3 Dicerna GalNAc Delivery Technology Introduction

11.7.4 Dicerna Revenue in GalNAc Delivery Technology Business (2019-2024)

11.7.5 Dicerna Recent Development

11.8 Arbutus

11.8.1 Arbutus Company Details

11.8.2 Arbutus Business Overview

11.8.3 Arbutus GalNAc Delivery Technology Introduction

11.8.4 Arbutus Revenue in GalNAc Delivery Technology Business (2019-2024)

11.8.5 Arbutus Recent Development

11.9 Verve Therapeutics

11.9.1 Verve Therapeutics Company Details

11.9.2 Verve Therapeutics Business Overview

11.9.3 Verve Therapeutics GalNAc Delivery Technology Introduction

11.9.4 Verve Therapeutics Revenue in GalNAc Delivery Technology Business (2019-2024)

11.9.5 Verve Therapeutics Recent Development

11.10 Silence Therapeutics

11.10.1 Silence Therapeutics Company Details

11.10.2 Silence Therapeutics Business Overview

11.10.3 Silence Therapeutics GalNAc Delivery Technology Introduction

11.10.4 Silence Therapeutics Revenue in GalNAc Delivery Technology Business (2019-2024)

11.10.5 Silence Therapeutics Recent Development

11.11 Luye Life Sciences (GeneLeap Biotech)

11.11.1 Luye Life Sciences (GeneLeap Biotech) Company Details

11.11.2 Luye Life Sciences (GeneLeap Biotech) Business Overview

11.11.3 Luye Life Sciences (GeneLeap Biotech) GalNAc Delivery Technology Introduction

11.11.4 Luye Life Sciences (GeneLeap Biotech) Revenue in GalNAc Delivery Technology Business (2019-2024)

11.11.5 Luye Life Sciences (GeneLeap Biotech) Recent Development

11.12 Hitgen

11.12.1 Hitgen Company Details

11.12.2 Hitgen Business Overview

11.12.3 Hitgen GalNAc Delivery Technology Introduction

11.12.4 Hitgen Revenue in GalNAc Delivery Technology Business (2019-2024)

11.12.5 Hitgen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Suzhou Ribo Life Science Co.,Ltd.

Sirnaomics

Ionis Pharmaceuticals

Alnylam

Arrowhead

Dicerna

Arbutus

Verve Therapeutics

Silence Therapeutics

HitGen LTD

Novo Nordisk (Dicerna)

Luye Life Sciences (GeneLeap Biotech)

List of Tables

Table 1. Global GalNAc Delivery Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of GalNAc-siRNA Based

Table 3. Key Players of GalNAc-ASO Based

Table 4. Global GalNAc Delivery Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global GalNAc Delivery Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global GalNAc Delivery Technology Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global GalNAc Delivery Technology Market Share by Region (2019-2024)

Table 8. Global GalNAc Delivery Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global GalNAc Delivery Technology Market Share by Region (2025-2030)

Table 10. GalNAc Delivery Technology Market Trends

Table 11. GalNAc Delivery Technology Market Drivers

Table 12. GalNAc Delivery Technology Market Challenges

Table 13. GalNAc Delivery Technology Market Restraints

Table 14. Global GalNAc Delivery Technology Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global GalNAc Delivery Technology Market Share by Players (2019-2024)

Table 16. Global Top GalNAc Delivery Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc Delivery Technology as of 2023)

Table 17. Ranking of Global Top GalNAc Delivery Technology Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by GalNAc Delivery Technology Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of GalNAc Delivery Technology, Headquarters and Area Served

Table 20. Global Key Players of GalNAc Delivery Technology, Product and Application

Table 21. Global Key Players of GalNAc Delivery Technology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global GalNAc Delivery Technology Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global GalNAc Delivery Technology Revenue Market Share by Type (2019-2024)

Table 25. Global GalNAc Delivery Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global GalNAc Delivery Technology Revenue Market Share by Type (2025-2030)

Table 27. Global GalNAc Delivery Technology Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global GalNAc Delivery Technology Revenue Market Share by Application (2019-2024)

Table 29. Global GalNAc Delivery Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global GalNAc Delivery Technology Revenue Market Share by Application (2025-2030)

Table 31. North America GalNAc Delivery Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America GalNAc Delivery Technology Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America GalNAc Delivery Technology Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe GalNAc Delivery Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe GalNAc Delivery Technology Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe GalNAc Delivery Technology Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific GalNAc Delivery Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific GalNAc Delivery Technology Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific GalNAc Delivery Technology Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America GalNAc Delivery Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America GalNAc Delivery Technology Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America GalNAc Delivery Technology Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa GalNAc Delivery Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa GalNAc Delivery Technology Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa GalNAc Delivery Technology Market Size by Country (2025-2030) & (US$ Million)

Table 46. Suzhou Ribo Life Science Co., Ltd Company Details

Table 47. Suzhou Ribo Life Science Co., Ltd Business Overview

Table 48. Suzhou Ribo Life Science Co., Ltd GalNAc Delivery Technology Product

Table 49. Suzhou Ribo Life Science Co., Ltd Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 50. Suzhou Ribo Life Science Co., Ltd Recent Development

Table 51. Sirnaomics Company Details

Table 52. Sirnaomics Business Overview

Table 53. Sirnaomics GalNAc Delivery Technology Product

Table 54. Sirnaomics Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 55. Sirnaomics Recent Development

Table 56. Novo Nordisk (Dicerna) Company Details

Table 57. Novo Nordisk (Dicerna) Business Overview

Table 58. Novo Nordisk (Dicerna) GalNAc Delivery Technology Product

Table 59. Novo Nordisk (Dicerna) Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 60. Novo Nordisk (Dicerna) Recent Development

Table 61. Ionis Pharmaceuticals Company Details

Table 62. Ionis Pharmaceuticals Business Overview

Table 63. Ionis Pharmaceuticals GalNAc Delivery Technology Product

Table 64. Ionis Pharmaceuticals Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 65. Ionis Pharmaceuticals Recent Development

Table 66. Alnylam Company Details

Table 67. Alnylam Business Overview

Table 68. Alnylam GalNAc Delivery Technology Product

Table 69. Alnylam Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 70. Alnylam Recent Development

Table 71. Arrowhead Company Details

Table 72. Arrowhead Business Overview

Table 73. Arrowhead GalNAc Delivery Technology Product

Table 74. Arrowhead Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 75. Arrowhead Recent Development

Table 76. Dicerna Company Details

Table 77. Dicerna Business Overview

Table 78. Dicerna GalNAc Delivery Technology Product

Table 79. Dicerna Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 80. Dicerna Recent Development

Table 81. Arbutus Company Details

Table 82. Arbutus Business Overview

Table 83. Arbutus GalNAc Delivery Technology Product

Table 84. Arbutus Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 85. Arbutus Recent Development

Table 86. Verve Therapeutics Company Details

Table 87. Verve Therapeutics Business Overview

Table 88. Verve Therapeutics GalNAc Delivery Technology Product

Table 89. Verve Therapeutics Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 90. Verve Therapeutics Recent Development

Table 91. Silence Therapeutics Company Details

Table 92. Silence Therapeutics Business Overview

Table 93. Silence Therapeutics GalNAc Delivery Technology Product

Table 94. Silence Therapeutics Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 95. Silence Therapeutics Recent Development

Table 96. Luye Life Sciences (GeneLeap Biotech) Company Details

Table 97. Luye Life Sciences (GeneLeap Biotech) Business Overview

Table 98. Luye Life Sciences (GeneLeap Biotech) GalNAc Delivery Technology Product

Table 99. Luye Life Sciences (GeneLeap Biotech) Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 100. Luye Life Sciences (GeneLeap Biotech) Recent Development

Table 101. Hitgen Company Details

Table 102. Hitgen Business Overview

Table 103. Hitgen GalNAc Delivery Technology Product

Table 104. Hitgen Revenue in GalNAc Delivery Technology Business (2019-2024) & (US$ Million)

Table 105. Hitgen Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. GalNAc Delivery Technology Picture

Figure 2. Global GalNAc Delivery Technology Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global GalNAc Delivery Technology Market Share by Type: 2023 VS 2030

Figure 4. GalNAc-siRNA Based Features

Figure 5. GalNAc-ASO Based Features

Figure 6. Global GalNAc Delivery Technology Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global GalNAc Delivery Technology Market Share by Application: 2023 VS 2030

Figure 8. Cardiovascular Diseases Case Studies

Figure 9. Metabolic Diseases Case Studies

Figure 10. Neurological Diseases Case Studies

Figure 11. Other Case Studies

Figure 12. GalNAc Delivery Technology Report Years Considered

Figure 13. Global GalNAc Delivery Technology Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global GalNAc Delivery Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global GalNAc Delivery Technology Market Share by Region: 2023 VS 2030

Figure 16. Global GalNAc Delivery Technology Market Share by Players in 2023

Figure 17. Global Top GalNAc Delivery Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GalNAc Delivery Technology as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by GalNAc Delivery Technology Revenue in 2023

Figure 19. North America GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America GalNAc Delivery Technology Market Share by Country (2019-2030)

Figure 21. United States GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe GalNAc Delivery Technology Market Share by Country (2019-2030)

Figure 25. Germany GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific GalNAc Delivery Technology Market Share by Region (2019-2030)

Figure 33. China GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America GalNAc Delivery Technology Market Share by Country (2019-2030)

Figure 41. Mexico GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa GalNAc Delivery Technology Market Share by Country (2019-2030)

Figure 45. Turkey GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. UAE GalNAc Delivery Technology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Suzhou Ribo Life Science Co., Ltd Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 49. Sirnaomics Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 50. Novo Nordisk (Dicerna) Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 51. Ionis Pharmaceuticals Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 52. Alnylam Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 53. Arrowhead Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 54. Dicerna Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 55. Arbutus Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 56. Verve Therapeutics Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 57. Silence Therapeutics Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 58. Luye Life Sciences (GeneLeap Biotech) Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 59. Hitgen Revenue Growth Rate in GalNAc Delivery Technology Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global GalNAc based Drug Market Research Report 2024

Global GalNAc siRNA Conjugates Drug Market Research Report 2024

Global GalNAc Oligonucleotide Conjugates Market Research Report 2024

Global GalNAc and GalNAc Derivatives Market Research Report 2024

Global mRNA Delivery System Market Research Report 2024

Global GalNac Conjugates Market Research Report 2024

Liraglutide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Grade Polyglutamic Acid Market Research Report 2024

Global Targeted SSTR Radionuclide Drug Conjugates Market Research Report 2024

GPCR targeting Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fully Automatic SPR System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Gene Therapy Biomanufacturing Market Research Report 2024

Global Glucagon Like Peptide 2 Receptor Market Research Report 2024

Global Dulaglutide Market Research Report 2024

Global GalNAc ASO Conjugates Market Research Report 2024

SPR Instruments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Interfering RNA siRNA Therapeutics Market Insights Forecast to 2030

Global Oral Drug Delivery Market Research Report 2025

Global Advanced Glycosylation End Product Receptor AGER ELISA Kit Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions